Our board sets out our strategic priorities and policies.
It has 2 sub-committees:
- audit and risk committee
- remuneration committee.
Sharmila Nebhrajani OBE, chairman
Sharmila read medicine at the University of Oxford. Rather than pursuing further clinical studies she began an international business career in finance and strategy, specialising in telecoms, infrastructure and media. She had a 14-year career at the BBC including 9 years as chief operating officer at BBC Future Media and Technology, the division that built the iPlayer.
She has significant health and science experience having served on the boards of the Medical Research Council, the Association of Medical Research Charities, as deputy chairman of the Human Fertilisation and Embryology Authority and as chairman of the Human Tissue Authority.
She was most recently chief executive of Wilton Park, a not-for-profit agency of the Foreign and Commonwealth Office convening international policy dialogues on topics such as global health, regional and national security, climate change and artificial intelligence. She sits on a range of UK boards including Severn Trent plc, ITV plc, Halma plc and Coutts Bank. She is a World Fellow at the University of Yale and is on the Governing Council of Oxford University.
Sharmila was made an OBE in 2014 for services to medical research.
Dr Michael Borowitz
Dr Mark Chakravarty
Professor Gary Ford CBE, FMedSci
Gary is chief executive officer of Oxford Academic Health Science Network. He is also a consultant stroke physician at Oxford University Hospitals NHS Foundation Trust, and professor of stroke medicine at Oxford University. He is the current chair of 15 Academic Health Science Networks across England.
He has been part of many service innovations in UK stroke care in the last 20 years. This includes developing the first thrombolysis protocol for acute stroke in England and the Face Arm Speech Test.
Gary was director of the National Institute for Health Research (NIHR) stroke research network from 2005 to 2014. He was awarded a CBE in 2013 for services to research in stroke medicine. He is a member of the NIHR strategy board. In 2018, Gary was identified as one of 7 NIHR research legends whose work has transformed care in the NHS.
Alina has had a long career in publishing and information within the private sector, including 16 years at Thomson Reuters. Her leadership has focused on the digital transformation of information for professional markets, including health. She was previously the managing director of the publishing arm of the Royal Pharmaceutical Society, which publishes a wide range of digital medicines information, including the British National Formulary (BNF).
Today, Alina holds a portfolio of board and advisory positions across several professional and academic bodies. These include the Institute of Engineering and Technology, the Royal Society of Chemistry and Manchester University Press.
Professor Bee Wee CBE
Originally from Malaysia, Bee qualified from Trinity College Dublin in 1988, trained in general practice in Dublin, then moved into palliative medicine in Ireland, Hong Kong and the UK. As national clinical director for end of life care she led the Leadership Alliance for the Care of Dying People and is co-chair of the National Partnership for Palliative and End of Life Care.
Professor Wee is also consultant in palliative medicine at Sobell House and Katharine House Hospices, Oxford University Hospitals NHS Foundation Trust and associate professor at University of Oxford, where she is also a fellow of Harris Manchester College.
Dr Justin Whatling
Dr Justin Whatling is a medical doctor with 20 years’ experience in using technology and informatics to transform outcomes for patients. He leads health and life sciences for Palantir internationally. Prior to that he established and led Cerner's population health business outside of the USA. Justin held previous roles in BT Health, Accenture and ran a health outcomes business on behalf of Bupa
He is a founding fellow and member of the finance and audit committee and recent council member of the UK Faculty of Clinical Informatics. He is a fellow of the British Computer Society (BCS) and a member of their Academy of Computing board. He represents them on the management committee of the BMJ Health and Care Informatics journal and is a past chair for BCS Health. He also founded the Federation of Informatics Professionals.
Justin is a visiting professor in health informatics at University College London. He was previously an independent member of the NHS’s National Information Board, who set the strategy and direction for the health and care system in England on technology and information.
He has also completed 3 terms of office as a non-executive director of the BMJ publishing group. He has sat on the healthcare strategic advisory team of the Engineering and Physical Sciences Research Council.
Dr Sam Roberts, chief executive
Professor Jonathan Benger, CBE MD FRCS FRCEM, chief medical officer and interim director of the centre for guidelines
Mark Chapman, interim director of medical technology and digital evaluation
Helen Knight, director of medicines evaluation
Boryana Stambolova, interim director of finance
The following are not voting members of the board; along with the executive directors, they make up our executive team.